Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Pricing comparisons with competing GLP-1 support supplements
In the STEP trials, semaglutide 2.4 mg caused vomiting in 24.5% of participants versus 6.3% on placebo
Stacy Wood Patient Game changer
Understanding these differences is key to choosing the option that aligns with your health goals
Summary: Mounjaro (tirzepatide) can be safely injected into the upper arm, which is one of three MHRA-approved subcutaneous injection sites for this medication
Aggressively Control Blood Sugar: Patients who are undergoing aggressive control of their blood sugar levelsespecially those transitioning from poorly managed diabetesare at greater risk during the early stages of treatment
US$ 20.85
:max_bytes(150000):strip_icc()/VWH-GettyImages-2177964629-9f7413a5ef1b43cc9ba7cbdc67275974.jpg)
US$ 25.82
US$ 24.55
